Related Experiment Video
Updated: Apr 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Dyslipidaemia in children with Type 1 diabetes: Experience from a tertiary care hospitaln
Mohammad Raza1, Saba Shahid1, Sidra Maqsood2
1Department of Paediatrics, The Indus Hospital, Karachi, Pakistan.
Objectives:
To determine the lipid profile of children with type 1 diabetes, and to identify the risk factors associated with dyslipidaemia.
Methods:
The cross-sectional study was conducted at Indus Hospital's Korangi campus from January 2021 to March 2022, and comprised children of either gender aged up to 15 years having type 1 diabetes. Data included fasting lipid profile, thyroid-stimulating hormone level, tissue transglutaminase immunoglobulin A, serum immunoglobulin A level, urine analysis, urine-albumin creatinine ratio, and glycated haemoglobin level. Data was analysed using SPSS 21.
Results:
Of the 40 children, 24(60%) were boys and 16(40%) were girls. The overall median age was 8 years (interquartile range: 3.75-10 years), median body mass index was 15.9kg/m2 (interquartile range: 14.2-16.6kg/m2), and median duration of diabetes was 2 years (interquartile range: 1.7-4.5 years). Dyslipidaemia was seen in 22(55%) children, and gender had no significant association with it (p>0.05). Median total cholesterol, triglyceride, highdensity lipoprotein-cholesterol and low-density lipoprotein cholesterol values were significantly higher in children with dyslipidaemia (p<0.05). Also, children with dyslipidaemia had significantly higher blood pressure values compared to those not having dyslipidaemia (p<0.03).
Conclusions:
Lipid profile abnormalities were common in non-obese children with type 1 diabetes, and elevated blood pressure was significantly associated with dyslipidaemia in such children.
Related Concept Videos
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational

